Exclusive: ‘Highly problematic’ policy has Saudi university pressuring faculty to cite its research 

Prince Sultan University

At Prince Sultan University in Saudi Arabia, faculty members must help raise their school’s academic standing not by doing impactful work, but by citing the institution’s research in their papers, according to a document Retraction Watch has obtained.

In an interoffice memo from 2022, Ahmed Yamani, president of the Riyadh-based institution, referred to “the rule of the requirement of citing 3-4 relevant publications in each paper” whose aim was “increasing the exposure of PSU research work and increasing the total number of PSU citations.”

Coordinated citation efforts can boost the rankings of institutions and individual researchers. The Committee on Publication Ethics considers citation manipulation unethical

Continue reading Exclusive: ‘Highly problematic’ policy has Saudi university pressuring faculty to cite its research 

Exclusive: Reviewer recommended against publishing paper on DNA in COVID vaccines

Rolf Marschalek was on vacation when he saw a new paper had been published in the journal Autoimmunity. Marschalek, a biochemist at Goethe University Frankfurt in Germany, was “very upset,” he told Retraction Watch – because he’d peer-reviewed the manuscript and had recommended against publication. 

The authors of the paper claimed to find DNA in mRNA-based COVID-19 vaccines above regulators’ suggested amounts. The article appeared online September 6, and within weeks the publisher began an investigation into concerns about its content, as we reported previously.

In Marschalek’s initial review, which he provided to us, he detailed how Qubit fluorometry, one of the methods the authors used to measure the amount of DNA in the vaccine vials, was “not suited” for use when samples contain much higher amounts of RNA than DNA, as is the case with mRNA-based COVID-19 vaccines. He cited a paper he and colleagues had written about methods of quantifying amounts of RNA and DNA in mRNA vaccine vials, including Qubit. 

Continue reading Exclusive: Reviewer recommended against publishing paper on DNA in COVID vaccines

Exclusive: A misconduct ruling, a flawed investigation, and an attempted payoff

University of Melbourne

In April 2019, Daejung Kim, then a Ph.D. student at the University of Melbourne in Australia, found a draft manuscript on the desk of a postdoc in the same laboratory. The manuscript included the experimental results on metal alloys he had spent months collecting. Kim hadn’t been told about the paper, nor had anyone asked his permission to use the data. The findings were central to Kim’s Ph.D. thesis and publishing them would mean the data were no longer original. 

“I was shaking in the lab,” he recalled recently. “When I saw it, I couldn’t stop myself. I didn’t know what to do.” 

Kim took his concerns to his supervisor, Kenong Xia, a materials scientist and head of the lab, asking for his help to resolve the issue. He wanted to be credited as a coauthor on any papers using his results. He also emailed the postdoc, Ahmad Zafari, asking to see a draft of the paper. 

Continue reading Exclusive: A misconduct ruling, a flawed investigation, and an attempted payoff

Exclusive: Web of Science company involved in dubious awards in Iraq

Hayder A. Dhahad, Iraq’s deputy minister for scientific research affairs, speaks at an awards ceremony at the country’s Science Day celebration.
Source: Instagram

In the string of prestigious awards Qusay Hassan, a mechanical engineer at the University of Diyala in Iraq, had received from the hands of his country’s minister for higher education and scientific research, the last two stood out: Each trophy carried the name and logo of the global analytics company Clarivate, a name seen widely as a key scholarly imprimatur.

The British-American firm runs the influential Web of Science Master Journal List, which it curates based on several quality criteria, and also calculates journal impact factors. The company says it takes retractions into account when calculating its highly coveted researcher designations

But Hassan, who has had 21 papers retracted, was one of several Iraqi scientists and institutions winning accolades at the ministry’s high-profile Iraq Education Conference 2025 in Baghdad earlier this month. At the award ceremony on October 11, a deputy minister said a Clarivate team helped develop the selection criteria for the awards, which were based on Web of Science data. Like the other winners, Hassan received his two trophies from the minister, Naeem Abd Yaser Al-Aboudi, after a Clarivate representative announced his name from the stage. 

Continue reading Exclusive: Web of Science company involved in dubious awards in Iraq

Exclusive: American Heart Association reviewing award to rocket scientist with seven retractions

The American Heart Association is reviewing its decision to give an award to the architect of a controversial theory that is the subject of eight seven retracted papers, Retraction Watch has learned. In the meantime, the researcher is using the award to contest several of the retractions. 

The Paul Dudley White International Scholar Award “recognizes the team of authors with the highest-ranked scientific abstract from every participating country for each AHA scientific meeting,” according to the award website.

At its Basic Cardiovascular Sciences 2025 conference in July, the association gave the award for best  abstract from India to work describing “Sanal flow choking” theory, which is named after lead author, V. R. Sanal Kumar, a professor of aerospace engineering at Amity University in New Delhi. As we have previously reported, some scientists have denounced the concept as “absolute nonsense” and “inaccurate and paradoxical” — and earlier this year, a journal said it “fundamentally violates” a law of thermodynamics. 

Continue reading Exclusive: American Heart Association reviewing award to rocket scientist with seven retractions

Exclusive: Journal to retract Alzheimer’s study after investigation finds misconduct

A journal says it will retract a 2019 paper on an Alzheimer’s treatment after an institutional investigation found research misconduct, according to emails seen by Retraction Watch. The move comes four years after another investigation by the same university uncovered image duplication in a different paper by a similar group of authors.

The paper, published in Biological Psychiatry, describes the potential of an apoE antagonist for treatment in Alzheimer’s disease. 

A 2019 news release by the University of South Florida, home to several of the researchers involved in the study, called the work “promising.” Lead author Darrell Sawmiller, an assistant professor at USF, said the study represented “the first time … we have direct evidence” apoE “acts as an essential molecule” in the mechanisms leading to Alzheimer’s. 

Continue reading Exclusive: Journal to retract Alzheimer’s study after investigation finds misconduct

Exclusive: Iraqi university forcing students to cite its journals to graduate

To earn their degrees, graduate students at the University of Technology in Baghdad not only must publish research in indexed journals. They also are required to cite articles in their school’s own publications, a document obtained by Retraction Watch shows.

Experts who reviewed the document called the citation requirement “deceptive and despicable” and said it could carry a steep price for the journals involved, one of which is indexed in Scopus.

Coercive citation is widespread in academia and can help boost the rankings of publications, institutions and individual researchers. The practice is considered unethical and may trigger heavy penalties.

Continue reading Exclusive: Iraqi university forcing students to cite its journals to graduate

Exclusive: Iraqi physicist fired by ministry over massive publishing scam

Oday A. Al-Owaedi

A professor of physics in Iraq was permanently dismissed last week after a government investigation found he orchestrated a massive fraudulent publishing scheme involving hundreds of thousands of dollars paid into his bank account by unwitting researchers, documents obtained by Retraction Watch show.

The scam included a deal between a prominent association of Iraqi academics and a predatory publisher, as well as the creation of a fake journal website and bogus acceptance letters purporting to be from reputed journals.

According to a ministerial order dated September 9 and obtained by Retraction Watch, the physicist, Oday A. Al-Owaedi, who also goes by several other names, defrauded “researchers by collecting money from them under the pretext of publishing their papers in reputable international journals as promised, while in fact falsifying and forging publication in fake websites.”

Continue reading Exclusive: Iraqi physicist fired by ministry over massive publishing scam

Exclusive: Publisher investigating DNA contamination paper that authors say CDC vaccine committee will consider

The publisher Taylor & Francis is investigating concerns raised on PubPeer about a paper claiming to find DNA contamination in COVID-19 vaccines beyond regulators’ recommended amounts. 

The move comes as the U.S. body tasked with making recommendations for vaccine use is scheduled to consider the safety of COVID-19 shots, and two of the study’s authors say their findings will be discussed.

The paper at issue was published September 6 in the journal Autoimmunity, a Taylor & Francis title. Scientific sleuth Kevin Patrick soon posted concerns on PubPeer, which he forwarded to the ethics department of the publisher. 

Continue reading Exclusive: Publisher investigating DNA contamination paper that authors say CDC vaccine committee will consider

Exclusive: Journal bans drug safety database papers as they flood the literature

celafon/iStockPhoto

Starting around 2023, a curious trend took hold in papers on drug safety monitoring. The number of articles published on an individual drug and its link to specific adverse events went from a steady increase to a huge spike. 

The data source in most of those articles was largely the same: The FDA Adverse Events Reporting System, or FAERS. In 2021, around 100 studies mining FAERS for drug safety signals were published. In 2024, that number was 600, with more than that already published this year. 

Two journals in particular published the bulk of these papers, Frontiers in Pharmacology and Expert Opinion on Drug Safety. In response to the flood, Frontiers started to require independent validation of studies drawing on public datasets. And Expert Opinion on Drug Safety decided in late July to stop accepting submissions altogether that use the FAERS database for this particular type of study. 

Continue reading Exclusive: Journal bans drug safety database papers as they flood the literature